Back
SPDR S&P Global Natural Resources ETF Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison
Sell
38
GNR
SPDR S&P Global Natural Resources ETF
Last Price:
$60.85
Seasonality Move:
1.98%
Sell
50
RYTM
Rhythm Pharmaceuticals, Inc.
Last Price:
$111.76
Seasonality Move:
-13.08%
Sell
38
SPDR S&P Global Natural Resources ETF (GNR)
is a Sell
Is SPDR S&P Global Natural Resources ETF a Buy, Sell or Hold?
-
The current SPDR S&P Global Natural Resources ETF [GNR] share price is $61.92. The Score for GNR is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
GNR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Rhythm Pharmaceuticals, Inc. (RYTM)
is a Sell
Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $111.86. The Score for RYTM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
RYTM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GNR Stock Price Chart
What is SPDR S&P Global Natural Resources ETF's stock price today?
-
The SPDR S&P Global Natural Resources ETF share price today is $61.92The current trend is moderately bearish and GNR is experiencing slight buying pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals, Inc.'s stock price today?
-
The Rhythm Pharmaceuticals, Inc. share price today is $111.86Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.
GNR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.69 | Buy |
| Relative Strength Index (14 RSI): | 58.2 | Buy |
| Chaikin Money Flow: | 310506 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (59.58 - 61.92) | Buy |
| Bollinger Bands (100): | (56.73 - 60.51) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.92 | Buy |
| Relative Strength Index (14 RSI): | 57.01 | Buy |
| Chaikin Money Flow: | -264527 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (99.99 - 110.55) | Buy |
| Bollinger Bands (100): | (94.91 - 108.39) | Buy |
GNR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 61.77 | Buy |
| 20-day SMA: | 60.9 | Buy |
| 50-day SMA: | 59.84 | Buy |
| 200-day SMA: | 55.88 | Buy |
| 8-day EMA: | 61.74 | Buy |
| 20-day EMA: | 61.13 | Buy |
| 50-day EMA: | 59.03 | Buy |
| 200-day EMA: | 37.14 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 109.83 | Buy |
| 20-day SMA: | 106.87 | Buy |
| 50-day SMA: | 105.94 | Buy |
| 200-day SMA: | 82.62 | Buy |
| 8-day EMA: | 24.86 | Buy |
| 20-day EMA: | 10.65 | Buy |
| 50-day EMA: | 4.39 | Buy |
| 200-day EMA: | 1.11 | Buy |
SPDR S&P Global Natural Resources ETF Earnings Growth & GNR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.99 per share, and an increase next year of $0.47 per share.
SPDR S&P Global Natural Resources ETF Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||